Compare DSL & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DSL | OMCL |
|---|---|---|
| Founded | 2013 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Computer Manufacturing |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | N/A | 2001 |
| Metric | DSL | OMCL |
|---|---|---|
| Price | $11.25 | $43.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $43.00 |
| AVG Volume (30 Days) | ★ 674.0K | 497.6K |
| Earning Date | 01-01-0001 | 10-30-2025 |
| Dividend Yield | ★ 11.72% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $1,177,740,000.00 |
| Revenue This Year | N/A | $8.61 |
| Revenue Next Year | N/A | $3.97 |
| P/E Ratio | ★ N/A | $102.68 |
| Revenue Growth | N/A | ★ 10.67 |
| 52 Week Low | $10.58 | $22.66 |
| 52 Week High | $12.95 | $47.69 |
| Indicator | DSL | OMCL |
|---|---|---|
| Relative Strength Index (RSI) | 34.01 | 74.57 |
| Support Level | $11.21 | $39.18 |
| Resistance Level | $11.39 | $45.36 |
| Average True Range (ATR) | 0.08 | 1.91 |
| MACD | 0.02 | 0.53 |
| Stochastic Oscillator | 25.53 | 85.53 |
DoubleLine Income Solutions Fund is a closed-end management investment company. Its primary investment objective is to seek high income and its secondary objective is to seek capital appreciation. It invests in debt securities and other income-producing investments anywhere in the world, including emerging markets. The company's investment portfolio comprises foreign corporate bonds, U.S. corporate bonds, bank loans, collateralized loan obligations, non-agency commercial mortgage backed obligations, asset-backed obligations, and municipal bonds among others.
Omnicell Inc provides automation and business analytics software for healthcare providers. The company is engaged in transforming the pharmacy and nursing care delivery model. The company helps its customers define and deliver cost-effective medication management designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks and drive improved clinical, operational, and financial outcomes across all care settings. The company derives the majority of its revenue from the United States.